GW&K Investment Management’s GSK GSK Stock Holding History

GW&K Investment Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$97K	Buy	1,760 +236	+15%	+$12.8K	﹤0.01%	456
2025 Q4	$75K	Sell	1,524 -19	-1%	-$886	﹤0.01%	489
2025 Q3	$67K	Sell	1,543 -39	-2%	-$1.52K	﹤0.01%	490
2025 Q2	$61K	Sell	1,582 -7	-0.4%	-$267	﹤0.01%	482
2025 Q1	$62K	Sell	1,589 -56	-3%	-$2.05K	﹤0.01%	455
2024 Q4	$56K	Hold	1,645	–	–	﹤0.01%	463
2024 Q3	$67K	Sell	1,645 -22	-1%	-$900	﹤0.01%	428
2024 Q2	$64K	Buy	1,667 +343	+26%	+$14.4K	﹤0.01%	418
2024 Q1	$57K	Buy	1,324 +31	+2%	+$1.28K	﹤0.01%	413
2023 Q4	$48K	Hold	1,293	–	–	﹤0.01%	411
2023 Q3	$47K	Hold	1,293	–	–	﹤0.01%	399
2023 Q2	$46K	Buy	1,293 +183	+16%	+$6.56K	﹤0.01%	388
2023 Q1	$39K	Buy	1,110 +758	+215%	+$26.5K	﹤0.01%	356
2022 Q4	$12K	Buy	352 +200	+132%	+$6.66K	﹤0.01%	363
2022 Q3	$4K	Hold	152	–	–	﹤0.01%	386
2022 Q2	$8K	Hold	152	–	–	﹤0.01%	499
2022 Q1	$8K	Hold	152	–	–	﹤0.01%	453
2021 Q4	$8K	Hold	152	–	–	﹤0.01%	374
2021 Q3	$7K	Hold	152	–	–	﹤0.01%	365
2021 Q2	$8K	Hold	152	–	–	﹤0.01%	379
2021 Q1	$7K	Hold	152	–	–	﹤0.01%	370
2020 Q4	$7K	Sell	152 -80	-34%	-$3.67K	﹤0.01%	366
2020 Q3	$11K	Buy	232 +80	+53%	+$4.01K	﹤0.01%	351
2020 Q2	$8K	Hold	152	–	–	﹤0.01%	349
2020 Q1	$7K	Hold	152	–	–	﹤0.01%	358
2019 Q4	$9K	Hold	152	–	–	﹤0.01%	368
2019 Q3	$8K	Buy	+152	New	+$7.82K	﹤0.01%	359
2018 Q4	–	Sell	-748,038	Closed	-$37.6M	–	291
2018 Q3	$37.6M	Sell	748,038 -14,784	-2%	-$751K	0.6%	46
2018 Q2	$38.4M	Sell	762,822 -21,392	-3%	-$1.08M	0.63%	44
2018 Q1	$38.3M	Buy	784,214 +78,592	+11%	+$3.66M	0.65%	43
2017 Q4	$31.3M	Sell	705,622 -122,004	-15%	-$5.64M	0.53%	70
2017 Q3	$42M	Sell	827,626 -7,551	-0.9%	-$383K	0.7%	44
2017 Q2	$45M	Buy	835,177 +21,415	+3%	+$1.14M	0.78%	38
2017 Q1	$42.9M	Buy	813,762 +122,844	+18%	+$6.23M	0.81%	32
2016 Q4	$33.3M	Sell	690,918 -46,446	-6%	-$2.29M	0.65%	55
2016 Q3	$39.8M	Buy	737,364 +141,171	+24%	+$7.74M	0.75%	39
2016 Q2	$32.3M	Buy	596,193 +39,414	+7%	+$2.08M	0.67%	55
2016 Q1	$28.2M	Buy	556,779 +111,461	+25%	+$5.55M	0.63%	64
2015 Q4	$22.5M	Sell	445,318 -28,251	-6%	-$1.44M	0.53%	83
2015 Q3	$22.8M	Buy	473,569 +13,923	+3%	+$725K	0.54%	77
2015 Q2	$23.9M	Buy	459,646 +36,356	+9%	+$2.05M	0.54%	77
2015 Q1	$24.4M	Buy	423,290 +181,371	+75%	+$10.4M	0.56%	75
2014 Q4	$12.9M	Buy	241,919 +46,844	+24%	+$2.62M	0.31%	116
2014 Q3	$11.2M	Buy	195,075 +6,927	+4%	+$425K	0.29%	114
2014 Q2	$12.6M	Sell	188,148 -71	-0%	-$4.81K	0.32%	107
2014 Q1	$12.6M	Buy	188,219 +5,221	+3%	+$353K	0.34%	110
2013 Q4	$12.2M	Buy	182,998 +8,248	+5%	+$535K	0.33%	104
2013 Q3	$11M	Buy	174,750 +12,760	+8%	+$821K	0.33%	102
2013 Q2	$10.1M	Buy	+161,990	New	+$10.3M	0.37%	103

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

GW&K Investment Management's GSK Position: Q1 2026 in Review

GW&K Investment Management increased its GSK (GSK) stake by 15% in Q1 2026, buying an estimated $12.8K and bringing the position to 1,760 shares worth $97K. The position accounts for ﹤0.01% of the portfolio, ranked #456.

GW&K Investment Management first reported a position in GSK in Q2 2013 and has held it in 49 quarters since. The position peaked at $45M in Q2 2017. 1,033 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

GW&K Investment Management held 1,760 shares of GSK worth $97K as of Q1 2026.
GW&K Investment Management bought 236 GSK shares in Q1 2026, an estimated $12.8K.
GSK made up ﹤0.01% of GW&K Investment Management's portfolio in Q1 2026, its #456 holding.
GW&K Investment Management first reported a position in GSK in Q2 2013 and has held it in 49 quarters since.
GW&K Investment Management's GSK position peaked at $45M in Q2 2017.
1,033 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on GW&K Investment Management's 13F filing for Q1 2026, filed 13 May 2026.